P408. Differences in biologic efficacy and dose-escalation among anti-TNF agents in Crohn's disease and ulcerative colitis

1. Ana Echarri Piudo
2. Lopez Casado
3. Rebeca Fraga Iriso
4. Virginia Ollero Pena
5. L. García Dieguez

Exportar

Exportar

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Exportar

×

Non se pode exportar o documento porque pertence a outro portal.

Texto completo

lock_openTexto completo externo lock_openTexto completo externo

DOI: 10.1093/ECCO-JCC/JJU027.527 GOOGLE SCHOLAR lock_openAcceso aberto editor

Outras publicacións en: Journal of Crohn's and Colitis

Obxectivos de Desenvolvemento Sustentable

•